Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Albireo Pharma (ALBO)
NASDAQ:ALBO
Albireo Pharma (ALBO) Financial Statements
0 Followers
Albireo Pharma Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 9.83M | $ 8.21M | $ 6.83M | $ 32.52M | $ 3.66M |
| Gross Profit | $ 9.22M | $ 7.43M | $ 6.60M | $ 31.60M | $ 3.23M |
| EBIT | $ -35.27M | $ -37.20M | $ -39.56M | $ -11.49M | $ 64.21M |
| EBITDA | $ -35.15M | $ -37.12M | $ -39.44M | $ -11.39M | $ 64.30M |
| Net Income Common Stockholders | $ -37.80M | $ -39.95M | $ -42.43M | $ -10.96M | $ 57.09M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 222.48M | $ 180.97M | $ 216.66M | $ 248.11M | $ 262.61M |
| Total Assets | $ 321.22M | $ 229.01M | $ 261.26M | $ 302.05M | $ 296.44M |
| Total Debt | $ 0.00 | $ 10.16M | $ 10.08M | $ 10.00M | $ 9.93M |
| Net Debt | $ -222.48M | $ -170.81M | $ -206.57M | $ -238.10M | $ -252.68M |
| Total Liabilities | $ 221.15M | $ 115.34M | $ 113.08M | $ 126.44M | $ 114.73M |
| Stockholders Equity | $ 100.07M | $ 113.68M | $ 148.19M | $ 175.61M | $ 181.72M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -29.67M | $ -37.08M | $ -35.64M | $ -13.89M | $ -27.67M |
| Operating Cash Flow | $ -29.63M | $ -36.39M | $ -35.41M | $ -13.89M | $ -27.48M |
| Investing Cash Flow | $ -40.00K | $ -685.00K | $ -235.00K | $ 0.00 | $ 103.20M |
| Financing Cash Flow | $ 121.48M | $ 1.80M | $ 4.38M | $ 370.00K | $ 762.00K |
Albireo Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.